Rhythm Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
02.03.26
/
50%
€81.50
Target price
02.03.27
€118.79
Performance (%)
10.43%
Price
28.07.26
€92.00
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr currently has a performance of 10.43%. This prediction currently runs until 02.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -0.541% | -0.541% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Canaccord Genuity Group Inc. from $141.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.00
16.06.26
16.06.26
€130.39
16.06.27
16.06.27
16.88%
28.07.26
28.07.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.03.23
02.03.23
€52.93
02.03.24
02.03.24
85.85%
03.03.24
03.03.24

